Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Calypte Biomedical Corporation (CALY) -- Ignore unavailable to you. Want to Upgrade?

To: Sherman Chen who wrote (204)	11/10/1997 3:35:00 PM
From: Cindy Powell	Read Replies (1) \| Respond to of 381

Hello Sherman, Yes, I think most all biotechs, including CALY, should be considered risky. Overall, there aren't alot of biotechs making money, but biotechs are supposed to be the wave of the future, so those folks who can tolerate the risks and the volatility of these biotechs that have unique and promising products will be well rewarded. I am watching CALY and adding to my position on these dips. I feel good about their product and their managment, for what it's worth, and I think we'll be okay. It' never fun to invest at a premium and then anxiously await an opportunity to get out with a break even -- but no one has a crystal ball, and trying to second guess the stock market is a mega challenge even for the market mavens, so don't feel badly. It seems like alot of this is just luck. It's all irrational anyway-- I see companies selling at well below book value that are just out of favor with wall street, -- and then I see people making out like bandits on alot of hyped up nearly worlthless stocks, so go fiqure. I hope we see some upward movemen, too-- but for now I am a buyer and not a seller. Gotta hate those reg S's with a passion though-- they are truly dispicable. Cindy